Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016.

Benjamin DanielsSallie-Anne PearsonNicholas A BuckleyClaudia BrunoHelga Zoega

Published in: Therapeutic advances in gastroenterology (2020)

Longer-term treatment with higher strength PPIs is common. Targeted regulation of PPI prescribing may improve the uptake of lower strength formulations and reduce both harms and costs associated with long-term PPI treatment.

Keyphrases

primary care
preterm infants
emergency department
combination therapy
protein protein
cancer therapy
small molecule
gestational age
preterm birth
adverse drug